Mirum Pharmaceuticals (MIRM) PT Raised to $112 at Baird

April 27, 2026 11:21 AM

Baird analyst Brian Skorney raised the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $112.00 (from $95.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found